PortfoliosLab logo
Accolade, Inc. (ACCD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US00437E1029

CUSIP

00437E102

IPO Date

Jul 2, 2020

Highlights

Market Cap

$575.59M

EPS (TTM)

-$2.28

Total Revenue (TTM)

$321.89M

Gross Profit (TTM)

$137.39M

EBITDA (TTM)

-$48.97M

Year Range

$3.08 - $8.05

Target Price

$7.03

Short %

2.55%

Short Ratio

1.52

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Accolade, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2025FebruaryMarchApril
-76.36%
59.19%
ACCD (Accolade, Inc.)
Benchmark (^GSPC)

Returns By Period


ACCD

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of ACCD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025101.46%1.16%0.14%0.57%105.26%
2024-5.75%-9.45%2.24%-27.19%-7.21%-49.44%14.53%5.85%-11.29%-17.66%21.77%-11.40%-71.52%
202349.81%-4.80%29.43%-5.91%-11.01%11.88%11.51%-10.19%-21.57%-38.56%34.31%37.57%54.17%
2022-27.54%-5.86%-2.34%-68.34%15.47%15.26%24.86%10.17%12.18%-5.60%-18.09%-11.78%-70.45%
202116.53%-12.57%2.37%10.54%0.68%7.57%-13.81%1.22%-11.00%-5.64%-35.49%2.69%-39.40%
20209.23%3.61%15.65%-9.90%48.23%-16.20%46.46%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACCD is 45, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ACCD is 4545
Overall Rank
The Sharpe Ratio Rank of ACCD is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of ACCD is 5353
Sortino Ratio Rank
The Omega Ratio Rank of ACCD is 5858
Omega Ratio Rank
The Calmar Ratio Rank of ACCD is 3535
Calmar Ratio Rank
The Martin Ratio Rank of ACCD is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Accolade, Inc. (ACCD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Accolade, Inc.. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchApril
-0.20
-0.27
ACCD (Accolade, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Accolade, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchApril
-88.25%
-18.90%
ACCD (Accolade, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Accolade, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Accolade, Inc. was 94.73%, occurring on Nov 4, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.73%Dec 11, 2020980Nov 4, 2024
-27.6%Aug 7, 202031Sep 21, 202016Oct 13, 202047
-25.24%Oct 15, 202013Nov 2, 202013Nov 19, 202026
-11.22%Dec 2, 20202Dec 3, 20203Dec 8, 20205
-9.63%Jul 13, 20202Jul 14, 20209Jul 27, 202011

Volatility

Volatility Chart

The current Accolade, Inc. volatility is 0.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%December2025FebruaryMarchApril
0.75%
9.03%
ACCD (Accolade, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Accolade, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Accolade, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 50.6% positive surprise.


-2.00-1.50-1.00-0.500.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-0.16
-0.32
Actual
Estimate

Valuation

The Valuation section provides an overview of how Accolade, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ACCD relative to other companies in the Health Information Services industry. Currently, ACCD has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ACCD in comparison with other companies in the Health Information Services industry. Currently, ACCD has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items